More than 2.7 million COVID-19 vaccinations administered in the 2023 autumn round In the 2023 autumn round, more than 2,731,000 people in the Netherlands received a COVID-19 vaccination. Vaccination coverage for people over 60 is currently 50.5%. Vaccination coverage varies by age group and region. COVID-19 vaccination was available until 22 December 2023.
Decrease in visits to GP only during first wave of COVID-19 crisis During the first wave of infections in the Netherlands during the COVID-19 crisis (March–June 2020), the total number of visits to the GP was 11% lower than during the same period in 2019.
More than 1 in 5 young people had suicidal thoughts during last lockdown More than 1 in 5 young people (22%) between the ages of 12 and 25 years seriously thought about ending their lives between December 2021 and February 2022. A lockdown was in effect in the Netherlands at that time.
People who work at night are more likely to get infected with coronavirus People who occasionally or regularly work at night are 37% more likely to test positive for coronavirus than people who only work during the daytime. This is one of the conclusions of a study by the RIVM (Netherlands).
First clients and care workers in mental healthcare vaccinated on Monday The first mental health clients in inpatient or residential care in four large institutions in the Netherlands will be vaccinated against COVID-19 this week.
RIVM collaborates at European level on the implemention of the Nutri-Score label The Netherlands, Belgium, France, Germany, Luxembourg, Spain and Switzerland are collaborating to facilitate the nutritional label NutriScore.
New research in GGD test lanes on spread of coronavirus SARS-CoV-2 RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.
Nationwide assessment of SARS-CoV-2 laboratories: very high quality The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.